Figure 3.
Representative plasma concentration-time data for a patient receiving carboplatin on cycle 1 (a) and cisplatin on cycle 2 (b) and for a patient receiving cisplatin on cycle 1 (c) and carboplatin on cycle 2 (d). □ Day 1; ▵ Day 2; ○ Day 3.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.